Page last updated: 2024-09-04

ezetimibe and fluorodeoxyglucose f18

ezetimibe has been researched along with fluorodeoxyglucose f18 in 1 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (fluorodeoxyglucose f18)	Trials (fluorodeoxyglucose f18)	Recent Studies (post-2010) (fluorodeoxyglucose f18)
2,484	563	1,465	34,771	2,160	20,111

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abela, GS; Abela, OG; Aziz, K; Berger, K; Janoudi, A; Patel, R; Rubinstein, J; Tamhane, U; Vedre, A	1

Other Studies

1 other study(ies) available for ezetimibe and fluorodeoxyglucose f18

Article	Year
Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography. Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:9 Topics: Animals; Anticholesteremic Agents; Aorta; Azetidines; C-Reactive Protein; Cholesterol; Crystallization; Ezetimibe; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis	2011

Article

Year

Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.

Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:9

Topics: Animals; Anticholesteremic Agents; Aorta; Azetidines; C-Reactive Protein; Cholesterol; Crystallization; Ezetimibe; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis

2011